Celltrion inks KRW 375.4B global biopharma supply deal, boosting CDMO momentum
Celltrion announced that it has signed a contract manufacturing (CMO) agreement with a global pharmaceutical company for the supply of drug substance. The counterparty remains undisclosed to ensure business confidentiality. Under the agreement, Celltrion will supply drug substance for three years from 2027 through 20…
